Basic Information
| RNALocate ID: | RLID:01001376 |
| RNA Symbol: | hsa-miR-29a-3p |
| Localization: | Nucleus |
RNA Information
| RNA Name: | hsa-miR-29a |
| RNA ID: | miRBase:MIMAT0000086 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 24918059 |
| Tissue/Cell Line: | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) |
| Method: | Microarray |
| Description: | Data are collected from supplementary Table S1.Top-ranking nucleolar miRNAs present in HeLa and MCF7 NCode arrays. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001371 | Cytoplasm | Hepatic carcinoma cells (Huh-7) | 29253196 |
| RLID:01001372 | Cytoplasm | Cell line (HeLa) | 21695135 |
| RLID:01001373 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001374 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01001375 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001377 | Nucleolus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:11000889 | Exosome | Lung cancer cell lines (A549|SK-MES) | 22753494 |
| RLID:11000890 | Exosome | Human milk | 28688106 |
| RLID:11000891 | Exosome | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
| RLID:11000892 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11000893 | Exosome | Renal cancer cells | 21670082 |
| RLID:11000894 | Exosome | Brain tissue | 23382797 |
| RLID:11000895 | Exosome | Plasma | 23663360 |
| RLID:11000896 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11000897 | Microvesicle | Plasma | 19951903 |
| RLID:11000898 | Microvesicle | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
| RLID:11000899 | Microvesicle | Plasma | 23077538 |
| RLID:11000900 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11000901 | Microvesicle | Follicular fluid | 23666971 |
| RLID:11000902 | Microvesicle | Hepatoma cells | 23771658 |
| RLID-D:11000022 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Lymphoma tissue|Mast cells|Seminal fluid|Tongue tissue | |
| RLID-D:11000285 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-29a-3p | Disease of metabolism | MNDR-E-MI-34768 |
| MNDR | hsa-miR-29a-3p | Idiopathic pulmonary fibrosis | MNDR-E-MI-34769 |
| MNDR | hsa-miR-29a-3p | Mantle cell lymphoma | MNDR-E-MI-34770 |
| MNDR | hsa-miR-29a-3p | Oral squamous cell carcinoma | MNDR-E-MI-34771 |
| MNDR | hsa-miR-29a-3p | Large cell neuroendocrine cancer | MNDR-E-MI-34772 |
| MNDR | hsa-miR-29a-3p | Medulloblastoma | MNDR-E-MI-34773 |
| MNDR | hsa-miR-29a-3p | B cell lymphoma of malt type | MNDR-E-MI-34774 |
| MNDR | hsa-miR-29a-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-34775 |
| MNDR | hsa-miR-29a-3p | Ovarian clear cell carcinoma | MNDR-E-MI-34776 |
| MNDR | hsa-miR-29a-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-34777 |
| MNDR | hsa-miR-29a-3p | Spinocerebellar ataxia type 17 | MNDR-E-MI-34778 |
| MNDR | hsa-miR-29a-3p | Lymphoma | MNDR-E-MI-34779 |
| MNDR | hsa-miR-29a-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-34780 |
| MNDR | hsa-miR-29a-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-34781 |
| MNDR | hsa-miR-29a-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-34782 |
| MNDR | hsa-miR-29a-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-34783 |
| MNDR | hsa-miR-29a-3p | Her2-receptor positive breast cancer | MNDR-E-MI-34784 |
| MNDR | hsa-miR-29a-3p | Niemann-pick disease type c | MNDR-E-MI-34785 |
| MNDR | hsa-miR-29a-3p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-34786 |
| MNDR | hsa-miR-29a-3p | B cell acute lymphoblastic leukemia | MNDR-E-MI-34787 |
| MNDR | hsa-miR-29a-3p | Dermatomyositis | MNDR-E-MI-34788 |
| MNDR | hsa-miR-29a-3p | Prostate cancer | MNDR-E-MI-34789 |
| MNDR | hsa-miR-29a-3p | B-cell chronic lymphocytic leukemia | MNDR-E-MI-34790 |
| MNDR | hsa-miR-29a-3p | Gastric cancer | MNDR-E-MI-34791 |
| MNDR | hsa-miR-29a-3p | Alzheimer disease | MNDR-E-MI-34792 |
| MNDR | hsa-miR-29a-3p | Sickle cell anemia | MNDR-E-MI-34793 |
| MNDR | hsa-miR-29a-3p | Intracranial aneurysm | MNDR-E-MI-34794 |
| MNDR | hsa-miR-29a-3p | Bladder cancer | MNDR-E-MI-34795 |
| MNDR | hsa-miR-29a-3p | Dysautonomia familial | MNDR-E-MI-34796 |
| MNDR | hsa-miR-29a-3p | Duchenne muscular dystrophy | MNDR-E-MI-34797 |
| MNDR | hsa-miR-29a-3p | Facioscapulohumeral muscular dystrophy | MNDR-E-MI-34798 |
| MNDR | hsa-miR-29a-3p | Head and neck cancer | MNDR-E-MI-34799 |
| MNDR | hsa-miR-29a-3p | Leukemia | MNDR-E-MI-34800 |
| MNDR | hsa-miR-29a-3p | Huntington disease | MNDR-E-MI-34801 |
| MNDR | hsa-miR-29a-3p | Chorea | MNDR-E-MI-34802 |
| MNDR | hsa-miR-29a-3p | Cardiovascular disease | MNDR-E-MI-34803 |
| MNDR | hsa-miR-29a-3p | Carotid stenosis | MNDR-E-MI-34804 |
| MNDR | hsa-miR-29a-3p | Moyamoya disease | MNDR-E-MI-34805 |
| MNDR | hsa-miR-29a-3p | Brain cancer | MNDR-E-MI-34806 |
| MNDR | hsa-miR-29a-3p | Lung cancer | MNDR-E-MI-34807 |
| MNDR | hsa-miR-29a-3p | Down syndrome | MNDR-E-MI-34808 |
| MNDR | hsa-miR-29a-3p | Parkinson disease | MNDR-E-MI-34809 |
| MNDR | hsa-miR-29a-3p | Machado-joseph disease | MNDR-E-MI-34810 |
| MNDR | hsa-miR-29a-3p | Niemann-pick disease | MNDR-E-MI-34811 |
| MNDR | hsa-miR-29a-3p | Basal-like breast cancer | MNDR-E-MI-34812 |
| MNDR | hsa-miR-29a-3p | Pituitary neoplasms | MNDR-E-MI-34813 |
| MNDR | hsa-miR-29a-3p | Pancreatic cancer | MNDR-E-MI-34814 |
| MNDR | hsa-miR-29a-3p | Melanoma | MNDR-E-MI-34815 |
| MNDR | hsa-miR-29a-3p | Rectum adenocarcinoma | MNDR-E-MI-34816 |
| MNDR | hsa-miR-29a-3p | Hepatitis B | MNDR-E-MI-34817 |
| MNDR | hsa-miR-29a-3p | Nephroblastoma | MNDR-E-MI-34818 |
| MNDR | hsa-miR-29a-3p | Colon cancer | MNDR-E-MI-34819 |
| MNDR | hsa-miR-29a-3p | Ischemic attack transient | MNDR-E-MI-34820 |
| MNDR | hsa-miR-29a-3p | Colon adenocarcinoma | MNDR-E-MI-34821 |
| MNDR | hsa-miR-29a-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-34822 |
| MNDR | hsa-miR-29a-3p | Familial ovarian cancer | MNDR-E-MI-34823 |
| MNDR | hsa-miR-29a-3p | Prostate adenocarcinoma | MNDR-E-MI-34824 |
| MNDR | hsa-miR-29a-3p | Kidney cancer | MNDR-E-MI-34825 |
| MNDR | hsa-miR-29a-3p | Cerebellar disease | MNDR-E-MI-34826 |
| MNDR | hsa-miR-29a-3p | Thyroid adenomas | MNDR-E-MI-34827 |
| MNDR | hsa-miR-29a-3p | Carcinoma ductal breast | MNDR-E-MI-34828 |
| MNDR | hsa-miR-29a-3p | Glioblastoma | MNDR-E-MI-34829 |
| MNDR | hsa-miR-29a-3p | Astrocytoma | MNDR-E-MI-34830 |
| MNDR | hsa-miR-29a-3p | Glioma | MNDR-E-MI-34831 |
| MNDR | hsa-miR-29a-3p | Nervous system cancer | MNDR-E-MI-34832 |
| MNDR | hsa-miR-29a-3p | Rhabdomyosarcoma | MNDR-E-MI-34833 |
| MNDR | hsa-miR-29a-3p | Chordoma | MNDR-E-MI-34834 |
| MNDR | hsa-miR-29a-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-34835 |
| MNDR | hsa-miR-29a-3p | Osteosarcoma | MNDR-E-MI-34836 |
| MNDR | hsa-miR-29a-3p | Liposarcoma | MNDR-E-MI-34837 |
| MNDR | hsa-miR-29a-3p | Inclusion body myositis | MNDR-E-MI-34838 |
| MNDR | hsa-miR-29a-3p | Meningioma | MNDR-E-MI-34839 |
| MNDR | hsa-miR-29a-3p | Gastric adenocarcinoma | MNDR-E-MI-34840 |
| MNDR | hsa-miR-29a-3p | Cervical squamous cell carcinoma | MNDR-E-MI-34841 |
| MNDR | hsa-miR-29a-3p | Pituitary adenoma | MNDR-E-MI-34842 |
| MNDR | hsa-miR-29a-3p | Lung squamous cell carcinoma | MNDR-E-MI-34843 |
| MNDR | hsa-miR-29a-3p | Non-small cell lung cancer | MNDR-E-MI-34844 |
| MNDR | hsa-miR-29a-3p | Adrenocortical cancer | MNDR-E-MI-34845 |
| MNDR | hsa-miR-29a-3p | Thyroid carcinoma | MNDR-E-MI-34846 |
| MNDR | hsa-miR-29a-3p | Papillary thyroid carcinoma | MNDR-E-MI-34847 |
| MNDR | hsa-miR-29a-3p | Bladder urothelial carcinoma | MNDR-E-MI-34848 |
| MNDR | hsa-miR-29a-3p | Pancreatic adenocarcinoma | MNDR-E-MI-34849 |
| MNDR | hsa-miR-29a-3p | Systemic scleroderma | MNDR-E-MI-34850 |
| MNDR | hsa-miR-29a-3p | Brain stem cancer | MNDR-E-MI-34851 |
| MNDR | hsa-miR-29a-3p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-34852 |
| MNDR | hsa-miR-29a-3p | Kidney renal clear cell carcinoma | MNDR-E-MI-34853 |
| MNDR | hsa-miR-29a-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-34854 |
| MNDR | hsa-miR-29a-3p | Renal clear cell carcinoma | MNDR-E-MI-34855 |
| MNDR | hsa-miR-29a-3p | Allergic rhinitis | MNDR-E-MI-34856 |
| MNDR | hsa-miR-29a-3p | Cholangiocarcinoma | MNDR-E-MI-34857 |
| MNDR | hsa-miR-29a-3p | Esophageal cancer | MNDR-E-MI-34858 |
| MNDR | hsa-miR-29a-3p | Liver cirrhosis | MNDR-E-MI-34859 |
| MNDR | hsa-miR-29a-3p | HIV | MNDR-E-MI-34860 |
| MNDR | hsa-miR-29a-3p | Lung small cell carcinoma | MNDR-E-MI-34861 |
| MNDR | hsa-miR-29a-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-34862 |
| MNDR | hsa-miR-29a-3p | T acute lymphoblastic leukemia | MNDR-E-MI-34863 |
| MNDR | hsa-miR-29a-3p | Acute t cell leukemia | MNDR-E-MI-34864 |
| MNDR | hsa-miR-29a-3p | Heart failure | MNDR-E-MI-34865 |
| MNDR | hsa-miR-29a-3p | Fibromyalgia | MNDR-E-MI-34866 |
| MNDR | hsa-miR-29a-3p | Breast invasive carcinoma | MNDR-E-MI-34867 |
| MNDR | hsa-miR-29a-3p | Early hepatocellular carcinoma | MNDR-E-MI-34868 |
| MNDR | hsa-miR-29a-3p | Familiar ovarian carcinoma | MNDR-E-MI-34869 |
| MNDR | hsa-miR-29a-3p | Aggressive b-cell lymphoma | MNDR-E-MI-34870 |
| MNDR | hsa-miR-29a-3p | Ankylosing spondylitis | MNDR-E-MI-34871 |
| MNDR | hsa-miR-29a-3p | Rheumatoid arthritis | MNDR-E-MI-34872 |
| MNDR | hsa-miR-29a-3p | Retinoblastoma | MNDR-E-MI-34873 |
| MNDR | hsa-miR-29a-3p | Neuroblastoma | MNDR-E-MI-34874 |
| MNDR | hsa-miR-29a-3p | Barrett's adenocarcinoma | MNDR-E-MI-34875 |
| MNDR | hsa-miR-29a-3p | Influenza | MNDR-E-MI-34876 |
| MNDR | hsa-miR-29a-3p | Chronic myelogenous leukemia | MNDR-E-MI-34877 |
| MNDR | hsa-miR-29a-3p | Hodgkin lymphoma | MNDR-E-MI-34878 |
| MNDR | hsa-miR-29a-3p | Ulcerative colitis | MNDR-E-MI-34879 |
| MNDR | hsa-miR-29a-3p | Burkitt lymphoma | MNDR-E-MI-34880 |
| MNDR | hsa-miR-29a-3p | Dementia vascular | MNDR-E-MI-34881 |
| MNDR | hsa-miR-29a-3p | Skin cutaneous melanoma | MNDR-E-MI-34882 |
| MNDR | hsa-miR-29a-3p | Skin melanoma | MNDR-E-MI-34883 |
| MNDR | hsa-miR-29a-3p | Acute myelocytic leukemia | MNDR-E-MI-34884 |
| MNDR | hsa-miR-29a-3p | Colorectal cancer | MNDR-E-MI-34885 |
| MNDR | hsa-miR-29a-3p | Nasopharynx carcinoma | MNDR-E-MI-34886 |
| MNDR | hsa-miR-29a-3p | Type 2 diabetes mellitus | MNDR-E-MI-34887 |
| MNDR | hsa-miR-29a-3p | Ependymoma | MNDR-E-MI-34888 |
| MNDR | hsa-miR-29a-3p | Cardiomegaly | MNDR-E-MI-34889 |
| MNDR | hsa-miR-29a-3p | Nasopharyngeal cancer | MNDR-E-MI-34890 |
| MNDR | hsa-miR-29a-3p | Sleep deprivation | MNDR-E-MI-34891 |
| MNDR | hsa-miR-29a-3p | Tendon injuries | MNDR-E-MI-34892 |
| MNDR | hsa-miR-29a-3p | Epstein-barr virus infections | MNDR-E-MI-34893 |
| MNDR | hsa-miR-29a-3p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-34894 |
| MNDR | hsa-miR-29a-3p | Sarcopenia | MNDR-E-MI-34895 |
| MNDR | hsa-miR-29a-3p | Stroke lacunar | MNDR-E-MI-34896 |
| MNDR | hsa-miR-29a-3p | Barrett's carcinogenesis | MNDR-E-MI-34897 |
| MNDR | hsa-miR-29a-3p | Breast cancer her3+ negative | MNDR-E-MI-34898 |
| MNDR | hsa-miR-29a-3p | Duke B | MNDR-E-MI-34899 |
| MNDR | hsa-miR-29a-3p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-34900 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABL1 | Homo sapiens | RR00026977 |
TOP